Abstract
ObjectiveWe examined the correlation between the dosing regimen of oral prednisolone (PSL) and the achievement of minimal manifestation status or better on PSL ≤5 mg/day lasting >6 months (the treatment...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have